PlainBillCongress, translated.Legislation. Context. Public interest.Became Public Law No: 114-104.
Congressional Research Service
Version 49 · Public Law · Dec 18, 2015
(This measure has not been amended since it was reported to the Senate on December 3, 2015. The summary of that version is repeated here.)
Stem Cell Therapeutic and Research Reauthorization Act of 2015
(Sec. 2) This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.)
The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program. (Sec. 3) Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised.
(Sec. 4) HHS must determine whether to include peripheral blood stem cells and umbilical cord blood in the definition of human organ.
People & committees
Rep. Smith, Christopher H. [R-NJ-4] · R–NJ
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Became Public Law No: 114-104.
Became Public Law No: 114-104.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Motion to reconsider laid on the table Agreed to without objection.
On motion that the House suspend the rules and agree to the Senate amendment Agreed to by the Yeas and Nays: (2/3 required): 421 - 0 (Roll no. 695). (text as House agreed to Senate amendment: CR H9333)
House roll call 695 · Individual votesResolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by the Yeas and Nays: (2/3 required): 421 - 0 (Roll no. 695).(text as House agreed to Senate amendment: CR H9333)
House roll call 695 · Individual votesAt the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the chair announced that further proceedings on the motion would be postponed.
DEBATE - The House proceeded with forty minutes of debate on the motion to suspend the rules and concur in the Senate amendment to H.R. 2820.
Mr. Pitts moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H9333-9335, H9339)
Message on Senate action sent to the House.
Passed Senate with an amendment by Unanimous Consent. (consideration: CR S8560; text as passed Senate: CR S8560)
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(consideration: CR S8560; text as passed Senate: CR S8560)
Placed on Senate Legislative Calendar under General Orders. Calendar No. 311.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5801)
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H5801)
DEBATE - The House proceeded with forty minutes of debate on H.R. 2820.
Considered under suspension of the rules. (consideration: CR H5801-5804)
Mr. Guthrie moved to suspend the rules and pass the bill.
Placed on the Union Calendar, Calendar No. 183.
Reported by the Committee on Energy and Commerce. H. Rept. 114-242.
Reported by the Committee on Energy and Commerce. H. Rept. 114-242.
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held.
Forwarded by Subcommittee to Full Committee by Voice Vote .
Subcommittee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Primary sources
Text links open the official source. We currently store references to these documents.
Source last updated: Dec 5, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze H.R.2820 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine H.R.2820 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine H.R.2820 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine H.R.2820 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.